Structure

Physi-Chem Properties

Molecular Weight:  486.23
Volume:  499.109
LogP:  3.944
LogD:  3.831
LogS:  -4.687
# Rotatable Bonds:  7
TPSA:  103.68
# H-Bond Aceptor:  8
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.34
Synthetic Accessibility Score:  4.032
Fsp3:  0.444
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.868
MDCK Permeability:  2.2253376300795935e-05
Pgp-inhibitor:  0.983
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.018
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.074

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.03
Plasma Protein Binding (PPB):  83.61124420166016%
Volume Distribution (VD):  0.782
Pgp-substrate:  22.76687240600586%

ADMET: Metabolism

CYP1A2-inhibitor:  0.076
CYP1A2-substrate:  0.974
CYP2C19-inhibitor:  0.501
CYP2C19-substrate:  0.916
CYP2C9-inhibitor:  0.589
CYP2C9-substrate:  0.865
CYP2D6-inhibitor:  0.017
CYP2D6-substrate:  0.543
CYP3A4-inhibitor:  0.498
CYP3A4-substrate:  0.893

ADMET: Excretion

Clearance (CL):  5.427
Half-life (T1/2):  0.284

ADMET: Toxicity

hERG Blockers:  0.038
Human Hepatotoxicity (H-HT):  0.034
Drug-inuced Liver Injury (DILI):  0.111
AMES Toxicity:  0.038
Rat Oral Acute Toxicity:  0.573
Maximum Recommended Daily Dose:  0.068
Skin Sensitization:  0.372
Carcinogencity:  0.016
Eye Corrosion:  0.003
Eye Irritation:  0.156
Respiratory Toxicity:  0.448

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC149735

Natural Product ID:  NPC149735
Common Name*:   Schisantherin F
IUPAC Name:   n.a.
Synonyms:   Schisantherin F
Standard InCHIKey:  KFTCQKGLZKQBNY-SEIIMYQLSA-N
Standard InCHI:  InChI=1S/C27H34O8/c1-9-13(2)27(30)35-26-20-16(11-19(31-5)24(26)33-7)10-14(3)15(4)22(29)17-12-18(28)23(32-6)25(34-8)21(17)20/h9,11-12,14-15,22,28-29H,10H2,1-8H3/b13-9-/t14-,15-,22+/m1/s1
SMILES:  C/C=C(/C)C(=O)Oc1c2-c3c(cc(c(c3OC)OC)O)[C@H]([C@H](C)[C@H](C)Cc2cc(c1OC)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465865
PubChem CID:   44567510
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota stems Honghe Prefecture of Yunnan Province, China 2005-Oct PMID[18278869]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. PMID[21232955]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1452 Cell Line C8166 Homo sapiens CC50 > 200000.0 nM PMID[465819]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 95230.0 nM PMID[465819]
NPT2 Others Unspecified Ratio = 4.32 n.a. PMID[465819]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC149735 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9793 High Similarity NPC477381
0.9726 High Similarity NPC477379
0.9724 High Similarity NPC474347
0.9724 High Similarity NPC474393
0.9658 High Similarity NPC470916
0.9521 High Similarity NPC477879
0.9517 High Similarity NPC474054
0.9452 High Similarity NPC183083
0.9452 High Similarity NPC295297
0.9452 High Similarity NPC137352
0.9404 High Similarity NPC473323
0.9379 High Similarity NPC87883
0.9338 High Similarity NPC476065
0.9333 High Similarity NPC475141
0.9272 High Similarity NPC473736
0.9216 High Similarity NPC475592
0.9205 High Similarity NPC24562
0.9145 High Similarity NPC473425
0.9139 High Similarity NPC471154
0.9103 High Similarity NPC249070
0.9079 High Similarity NPC126405
0.9079 High Similarity NPC53669
0.9079 High Similarity NPC308739
0.9079 High Similarity NPC217708
0.9079 High Similarity NPC77237
0.9079 High Similarity NPC474606
0.9079 High Similarity NPC297271
0.9079 High Similarity NPC16791
0.9073 High Similarity NPC475756
0.9034 High Similarity NPC471183
0.9032 High Similarity NPC215400
0.9032 High Similarity NPC230531
0.902 High Similarity NPC312763
0.9 High Similarity NPC187398
0.9 High Similarity NPC476348
0.8981 High Similarity NPC473445
0.8981 High Similarity NPC42797
0.8966 High Similarity NPC156948
0.8966 High Similarity NPC86605
0.8966 High Similarity NPC3072
0.8966 High Similarity NPC865
0.8966 High Similarity NPC46277
0.8966 High Similarity NPC301765
0.8961 High Similarity NPC238834
0.8947 High Similarity NPC224472
0.8933 High Similarity NPC476347
0.8933 High Similarity NPC178129
0.8924 High Similarity NPC291977
0.8903 High Similarity NPC469474
0.8897 High Similarity NPC133025
0.8896 High Similarity NPC198461
0.8882 High Similarity NPC294522
0.8882 High Similarity NPC21184
0.8882 High Similarity NPC120426
0.8882 High Similarity NPC205727
0.8874 High Similarity NPC198129
0.8874 High Similarity NPC252281
0.8874 High Similarity NPC477375
0.8874 High Similarity NPC316676
0.8874 High Similarity NPC325720
0.8874 High Similarity NPC327352
0.8816 High Similarity NPC322426
0.8816 High Similarity NPC477376
0.8816 High Similarity NPC176903
0.8816 High Similarity NPC30688
0.8816 High Similarity NPC477374
0.88 High Similarity NPC163898
0.8792 High Similarity NPC469630
0.879 High Similarity NPC328122
0.8782 High Similarity NPC29727
0.8767 High Similarity NPC471719
0.8759 High Similarity NPC7515
0.8759 High Similarity NPC469659
0.8759 High Similarity NPC56764
0.8759 High Similarity NPC276026
0.8759 High Similarity NPC555
0.8759 High Similarity NPC289258
0.8759 High Similarity NPC206737
0.8759 High Similarity NPC188378
0.8758 High Similarity NPC473989
0.8758 High Similarity NPC316989
0.875 High Similarity NPC252402
0.875 High Similarity NPC473408
0.875 High Similarity NPC102934
0.8742 High Similarity NPC40222
0.8742 High Similarity NPC268515
0.8733 High Similarity NPC471763
0.8726 High Similarity NPC125495
0.8725 High Similarity NPC469564
0.8718 High Similarity NPC155015
0.8718 High Similarity NPC142479
0.8716 High Similarity NPC267291
0.871 High Similarity NPC470769
0.871 High Similarity NPC150442
0.8707 High Similarity NPC105493
0.8699 High Similarity NPC214853
0.8699 High Similarity NPC240279
0.8699 High Similarity NPC55239
0.8699 High Similarity NPC180602
0.8693 High Similarity NPC85141
0.8693 High Similarity NPC106138
0.8693 High Similarity NPC475250
0.8684 High Similarity NPC15577
0.8675 High Similarity NPC318286
0.8675 High Similarity NPC166506
0.8675 High Similarity NPC327651
0.8675 High Similarity NPC110763
0.8675 High Similarity NPC197352
0.8675 High Similarity NPC189239
0.8667 High Similarity NPC110067
0.8667 High Similarity NPC91492
0.8667 High Similarity NPC6568
0.8667 High Similarity NPC7439
0.8667 High Similarity NPC34245
0.8667 High Similarity NPC256555
0.8658 High Similarity NPC311530
0.8654 High Similarity NPC7178
0.8654 High Similarity NPC62903
0.8645 High Similarity NPC176186
0.8645 High Similarity NPC264875
0.8645 High Similarity NPC169404
0.8645 High Similarity NPC53587
0.8645 High Similarity NPC163598
0.8645 High Similarity NPC120774
0.8642 High Similarity NPC311912
0.863 High Similarity NPC309744
0.863 High Similarity NPC135127
0.863 High Similarity NPC111635
0.8627 High Similarity NPC93924
0.8627 High Similarity NPC236166
0.8618 High Similarity NPC205361
0.8618 High Similarity NPC321958
0.8618 High Similarity NPC321696
0.8616 High Similarity NPC63061
0.8616 High Similarity NPC24627
0.8609 High Similarity NPC121661
0.8609 High Similarity NPC73467
0.8609 High Similarity NPC326144
0.86 High Similarity NPC131971
0.86 High Similarity NPC278469
0.86 High Similarity NPC193722
0.8591 High Similarity NPC266197
0.8591 High Similarity NPC109240
0.8591 High Similarity NPC291101
0.859 High Similarity NPC477377
0.859 High Similarity NPC476154
0.859 High Similarity NPC65591
0.859 High Similarity NPC178574
0.8589 High Similarity NPC88557
0.8581 High Similarity NPC474886
0.8581 High Similarity NPC126206
0.8571 High Similarity NPC469475
0.8571 High Similarity NPC47398
0.8571 High Similarity NPC234333
0.8571 High Similarity NPC260898
0.8571 High Similarity NPC469518
0.8571 High Similarity NPC113790
0.8562 High Similarity NPC275125
0.8562 High Similarity NPC475840
0.8562 High Similarity NPC170239
0.8562 High Similarity NPC97937
0.8553 High Similarity NPC37502
0.8553 High Similarity NPC40702
0.8553 High Similarity NPC267627
0.8552 High Similarity NPC309787
0.8552 High Similarity NPC184928
0.8552 High Similarity NPC141493
0.8544 High Similarity NPC54928
0.8543 High Similarity NPC76415
0.8543 High Similarity NPC324962
0.8543 High Similarity NPC218510
0.8543 High Similarity NPC138212
0.8535 High Similarity NPC268484
0.8533 High Similarity NPC471389
0.8533 High Similarity NPC83375
0.8533 High Similarity NPC224876
0.8533 High Similarity NPC87725
0.8533 High Similarity NPC263261
0.8533 High Similarity NPC300611
0.8526 High Similarity NPC75695
0.8526 High Similarity NPC272566
0.8526 High Similarity NPC477378
0.8526 High Similarity NPC476434
0.8526 High Similarity NPC475229
0.8523 High Similarity NPC13067
0.8523 High Similarity NPC22517
0.8523 High Similarity NPC114171
0.8523 High Similarity NPC43500
0.8523 High Similarity NPC164148
0.8523 High Similarity NPC6300
0.8523 High Similarity NPC230124
0.8516 High Similarity NPC24425
0.8514 High Similarity NPC16435
0.8514 High Similarity NPC162659
0.8514 High Similarity NPC306441
0.8514 High Similarity NPC234952
0.8514 High Similarity NPC265433
0.8514 High Similarity NPC471664
0.8514 High Similarity NPC472334
0.8514 High Similarity NPC248727

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC149735 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8333 Intermediate Similarity NPD1653 Approved
0.8313 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD1465 Phase 2
0.8288 Intermediate Similarity NPD3027 Phase 3
0.8253 Intermediate Similarity NPD5844 Phase 1
0.8243 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8243 Intermediate Similarity NPD1613 Approved
0.821 Intermediate Similarity NPD6234 Discontinued
0.8125 Intermediate Similarity NPD37 Approved
0.8086 Intermediate Similarity NPD4967 Phase 2
0.8086 Intermediate Similarity NPD4965 Approved
0.8086 Intermediate Similarity NPD4966 Approved
0.8084 Intermediate Similarity NPD7228 Approved
0.8027 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD1934 Approved
0.8 Intermediate Similarity NPD7199 Phase 2
0.7973 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD7473 Discontinued
0.7882 Intermediate Similarity NPD7074 Phase 3
0.7881 Intermediate Similarity NPD4060 Phase 1
0.787 Intermediate Similarity NPD3818 Discontinued
0.7857 Intermediate Similarity NPD6166 Phase 2
0.7857 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD6232 Discontinued
0.7836 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD7054 Approved
0.7806 Intermediate Similarity NPD7266 Discontinued
0.7805 Intermediate Similarity NPD3817 Phase 2
0.7798 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7472 Approved
0.7758 Intermediate Similarity NPD3882 Suspended
0.7744 Intermediate Similarity NPD2801 Approved
0.7744 Intermediate Similarity NPD7819 Suspended
0.7711 Intermediate Similarity NPD7075 Discontinued
0.7679 Intermediate Similarity NPD8127 Discontinued
0.7658 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD3750 Approved
0.7644 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD422 Phase 1
0.7616 Intermediate Similarity NPD4908 Phase 1
0.7597 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD5124 Phase 1
0.7595 Intermediate Similarity NPD1652 Phase 2
0.7595 Intermediate Similarity NPD6674 Discontinued
0.7586 Intermediate Similarity NPD7251 Discontinued
0.7586 Intermediate Similarity NPD7240 Approved
0.758 Intermediate Similarity NPD5762 Approved
0.758 Intermediate Similarity NPD5763 Approved
0.7547 Intermediate Similarity NPD4628 Phase 3
0.7543 Intermediate Similarity NPD7808 Phase 3
0.7543 Intermediate Similarity NPD7549 Discontinued
0.7532 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD6797 Phase 2
0.7517 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1511 Approved
0.7516 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6190 Approved
0.75 Intermediate Similarity NPD1610 Phase 2
0.75 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD6559 Discontinued
0.7485 Intermediate Similarity NPD5402 Approved
0.7484 Intermediate Similarity NPD230 Phase 1
0.7484 Intermediate Similarity NPD6355 Discontinued
0.747 Intermediate Similarity NPD6801 Discontinued
0.7455 Intermediate Similarity NPD4380 Phase 2
0.7451 Intermediate Similarity NPD4625 Phase 3
0.744 Intermediate Similarity NPD7768 Phase 2
0.7423 Intermediate Similarity NPD1512 Approved
0.7423 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD5494 Approved
0.7407 Intermediate Similarity NPD6799 Approved
0.7403 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD5403 Approved
0.7368 Intermediate Similarity NPD6959 Discontinued
0.7349 Intermediate Similarity NPD6599 Discontinued
0.7342 Intermediate Similarity NPD3748 Approved
0.7333 Intermediate Similarity NPD6842 Approved
0.7333 Intermediate Similarity NPD6843 Phase 3
0.7333 Intermediate Similarity NPD6841 Approved
0.7326 Intermediate Similarity NPD7229 Phase 3
0.732 Intermediate Similarity NPD2861 Phase 2
0.732 Intermediate Similarity NPD3018 Phase 2
0.7308 Intermediate Similarity NPD3620 Phase 2
0.7308 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD2797 Approved
0.7296 Intermediate Similarity NPD6100 Approved
0.7296 Intermediate Similarity NPD6099 Approved
0.7289 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD7685 Pre-registration
0.7285 Intermediate Similarity NPD4749 Approved
0.7278 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD447 Suspended
0.7258 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD3751 Discontinued
0.7256 Intermediate Similarity NPD2533 Approved
0.7256 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD5401 Approved
0.7256 Intermediate Similarity NPD2532 Approved
0.7256 Intermediate Similarity NPD2534 Approved
0.7255 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD919 Approved
0.723 Intermediate Similarity NPD1548 Phase 1
0.7226 Intermediate Similarity NPD7095 Approved
0.7222 Intermediate Similarity NPD4110 Phase 3
0.7222 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD8455 Phase 2
0.7216 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD6653 Approved
0.7207 Intermediate Similarity NPD8313 Approved
0.7207 Intermediate Similarity NPD8312 Approved
0.7205 Intermediate Similarity NPD1549 Phase 2
0.7202 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD7411 Suspended
0.7197 Intermediate Similarity NPD4140 Approved
0.7195 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD3749 Approved
0.7193 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD1551 Phase 2
0.7188 Intermediate Similarity NPD2935 Discontinued
0.7182 Intermediate Similarity NPD8434 Phase 2
0.7179 Intermediate Similarity NPD6798 Discontinued
0.7179 Intermediate Similarity NPD3268 Approved
0.7171 Intermediate Similarity NPD2983 Phase 2
0.7171 Intermediate Similarity NPD2982 Phase 2
0.7152 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3705 Approved
0.7143 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD6666 Approved
0.7134 Intermediate Similarity NPD6667 Approved
0.7133 Intermediate Similarity NPD4626 Approved
0.7126 Intermediate Similarity NPD3787 Discontinued
0.7126 Intermediate Similarity NPD3686 Approved
0.7126 Intermediate Similarity NPD3687 Approved
0.7123 Intermediate Similarity NPD5283 Phase 1
0.7117 Intermediate Similarity NPD8166 Discontinued
0.7108 Intermediate Similarity NPD6273 Approved
0.7105 Intermediate Similarity NPD7680 Approved
0.7105 Intermediate Similarity NPD2981 Phase 2
0.7091 Intermediate Similarity NPD4357 Discontinued
0.7086 Intermediate Similarity NPD3926 Phase 2
0.7086 Intermediate Similarity NPD3496 Discontinued
0.7083 Intermediate Similarity NPD3226 Approved
0.7081 Intermediate Similarity NPD2438 Suspended
0.7081 Intermediate Similarity NPD2796 Approved
0.7076 Intermediate Similarity NPD5353 Approved
0.7076 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD7985 Registered
0.7067 Intermediate Similarity NPD5691 Approved
0.7063 Intermediate Similarity NPD7097 Phase 1
0.7055 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD6832 Phase 2
0.7047 Intermediate Similarity NPD5536 Phase 2
0.7039 Intermediate Similarity NPD1091 Approved
0.7039 Intermediate Similarity NPD1611 Approved
0.7027 Intermediate Similarity NPD7157 Approved
0.7027 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD6233 Phase 2
0.7019 Intermediate Similarity NPD7033 Discontinued
0.7019 Intermediate Similarity NPD1510 Phase 2
0.7013 Intermediate Similarity NPD3225 Approved
0.7012 Intermediate Similarity NPD3892 Phase 2
0.7012 Intermediate Similarity NPD7982 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD4666 Phase 3
0.7 Intermediate Similarity NPD5090 Approved
0.7 Intermediate Similarity NPD5089 Approved
0.6994 Remote Similarity NPD2424 Discontinued
0.6993 Remote Similarity NPD1608 Approved
0.6989 Remote Similarity NPD5242 Approved
0.6986 Remote Similarity NPD228 Approved
0.6982 Remote Similarity NPD4005 Discontinued
0.6982 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6981 Remote Similarity NPD1240 Approved
0.6975 Remote Similarity NPD6032 Approved
0.697 Remote Similarity NPD2677 Approved
0.6954 Remote Similarity NPD5709 Phase 3
0.6948 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6946 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6946 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6943 Remote Similarity NPD1008 Clinical (unspecified phase)
0.6939 Remote Similarity NPD7843 Approved
0.6937 Remote Similarity NPD4340 Discontinued
0.6937 Remote Similarity NPD5735 Approved
0.6933 Remote Similarity NPD6004 Phase 3
0.6933 Remote Similarity NPD6002 Phase 3
0.6933 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6933 Remote Similarity NPD6005 Phase 3
0.6933 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6933 Remote Similarity NPD2029 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data